FDA Approves Lilly's Omvoh® (Mirikizumab-Mrkz) For Crohn's Disease, Expanding Its Use To The Second Major Type Of Inflammatory Bowel Disease
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...
Zawya2d
FDA approves Tirzepatideas: The first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...
Medpage Today on MSN1d
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
Princess of Wales Kate Middleton made a personal visit to thank the medical staff and speak with patients at the Royal ...
Ulcerative Colitis Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical trials, Medication, Therapies, Prevalence and Companies by DelveInsight
The key Ulcerative Colitis therapies expected to launch in the market include Jyseleca (filgotinib), Rinvoq (Upadacitinib), ...
usaherald7h
City of Meriden Sues Drug Makers Over Alleged Insulin Pricing Scheme
The city of Meriden, Connecticut, filed a lawsuit in federal court on Monday, accusing 20 companies, including major drug manufacturers such as CVS Health Corp., Eli Lilly and Co., and Novo Nordisk ...
pharmaphorum2d
Lilly adds another sales channel for obesity drug Zepbound
Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy ... president of Lilly Cardiometabolic Health and Lilly USA. "Our goal is to break down barriers and provide ...
PipelineReview.com2d
Lilly to acquire Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program
The acquisition will expand Lilly's oncology pipeline with STX-478, the differentiated and potentially best-in-class, mutant-selective PI3Kα inhibitor ...
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
In a bid to bring down the cost of insulin, California under Gov. Gavin Newsom inked a contract to produce the drug. It's years behind the timeline he announced.
TMCnet2d
Amphista Therapeutics appoints Paul Medeiros as Chief Business Officer
Cambridge, UK, 13 January 2025 – Amphista Therapeutics, a leader in the discovery of next-generation, Targeted, Protein ...
Grand Old Pivot: How COVID, economic development and a changing GOP defined the Holcomb era
The outgoing governor, who had never been elected to political office before, left his imprint on Indiana during his eight years.
Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
PipelineReview.com6d
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies
LONDON, UK & SAN FRANCISCO, CA, USA I January 09, 2025 I Verdiva Bio Limited (“Verdiva” or “the Company”) today announced its launch as a clinical-stage ...